摘要
本文采用血流变学研究了清栓酶预防治疗44例 TIA 患者,并对预防3年的效果进行了分析.其中发现首次疗前血流变值与健康人(ηP、RCT 除外)相比,差异显著(P<0.05或P<0.01).疗后差异不显著(P>0.05).疗前疗后相比差异显著(P<0.05)。用清栓酶每6个月预防治疗一次,血流变值与首次相比约下降50%～60%左右,而每年(12个月)预防治疗一次约下降30%～35%左右,其中治疗间歇时间一样,同年度血流变的值(ηP、RCT 除外)相比差异不显著(P>0.05),而治疗间歇时间不一样(6、12个月)同年度相比差异显著(P<0.05或 P<0.01).从而证实了清栓酶不但是治栓的佳药,也是防栓的良药,本文认为中、老年人预防脑中风,最好每年用清栓酶2次以上,才能提高预防效果.
In this paper,wc used Qingshuanmci as preventive medicine to trcat TIA and analysied its preventive effects.The results shown that every value of hcmorheology had signifi- cant difference [P value,except ηp,RCT] between before treatment and after treatment.It is concluded that Qingshuanmci was a good drug for preventing thrombosis,But we srggcsted that TIA was treated with Qingshuanmei Ad 2 vie in one year for prevention of cerebral apoplexy.
出处
《蛇志》
1992年第2期15-17,共3页
Journal of Snake
关键词
清栓酶
中风
预防
Qingshuanmei
preventive treatment
cerebral apoplexy
